Market revenue in 2023 | USD 41.0 million |
Market revenue in 2030 | USD 54.8 million |
Growth rate | 4.2% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Oncology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, Prenatal Testing, Endocrinology, Other Applications, Hematology, Infectious Diseases |
Key market players worldwide | Roche, Abbott Laboratories, Qiagen NV, Bayer AG, Nova Biomedical, Danaher Corp, Nipro Corp, Bio-Rad Laboratories Inc, Agilent Technologies Inc, BioMerieux SA, OraSure Technologies Inc, Abaxis |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care molecular diagnostics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 93.41% in 2023. Horizon Databook has segmented the Thailand point-of-care molecular diagnostics market based on oncology, prenatal testing, endocrinology, other applications, hematology, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
According to the data published by Roche, approximately 20% to 30% of the country’s population carries α-thalassemia, while 3%-9% carry β-thalassemia. The incidence of HbE is estimated to be around 54%, and Hb CS2 affects nearly 8% of the population. Moreover, it is estimated that about 30% to 40% of the population carries at least one of these abnormal genes.
Hence, increasing cases of blood-related disorders are expected to boost the adoption of POC diagnostic tests in the country. The test offers quick and accurate results, which provides timely identification of thalassemia cases. With the rising prevalence of thalassemia in Thailand, there is a growing need for efficient diagnostic tools to facilitate early detection and prompt intervention.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand point-of-care molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Thailand point-of-care molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account